SE
Shai Erlich
About
Erlich joined Quark in 1999 and since then has assumed several executive positions including Director of Portfolio Management and Product Development Strategic Planning. Dr. Erlich completed his studies at the School of Medicine at Ben Gurion University in Israel, and holds an M.Sc. in cancer genetics from the department of Human Genetics, Tel Aviv University, and a Ph.D. in Gene Therapy from the Department of Human Genetics, Mt Sinai Graduate School for Biomedical Sciences at the Mt. Sinai School of Medicine, New York.
Investment Focus
Contact Information
linkedin.com/in/••••••••
Find more investors like Shai
Search Investors